LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 37.71 | 27.76 | 2446 | 2877 | 0.8500 | 0.9520 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 37.71 | 27.76 | 2555 | 2877 | 0.8879 | 0.9648 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 39.41 | 27.76 | 85 | 3105 | 0.0274 | 0.1787 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 39.41 | 27.76 | 3276 | 3105 | 1.0549 | 1.0158 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 39.41 | 27.76 | 2450 | 3105 | 0.7889 | 0.9315 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 39.41 | 27.76 | 2701 | 3105 | 0.8697 | 0.9594 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 41.11 | 27.76 | 119 | 3331 | 0.0357 | 0.2346 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 41.11 | 27.76 | 3514 | 3331 | 1.0548 | 1.0155 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 41.11 | 27.76 | 2690 | 3331 | 0.8074 | 0.9390 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 41.11 | 27.76 | 2867 | 3331 | 0.8606 | 0.9570 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 42.81 | 27.76 | 133 | 3596 | 0.0370 | 0.2502 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 42.81 | 27.76 | 3882 | 3596 | 1.0794 | 1.0219 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 42.81 | 27.76 | 2866 | 3596 | 0.7969 | 0.9363 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 42.81 | 27.76 | 3050 | 3596 | 0.8481 | 0.9536 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 44.52 | 27.76 | 149 | 3884 | 0.0384 | 0.2658 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 44.52 | 27.76 | 4050 | 3884 | 1.0427 | 1.0118 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 44.52 | 27.76 | 2971 | 3884 | 0.7649 | 0.9262 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 44.52 | 27.76 | 3207 | 3884 | 0.8256 | 0.9470 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 46.22 | 27.76 | 180 | 4125 | 0.0436 | 0.2958 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 46.22 | 27.76 | 4360 | 4125 | 1.0570 | 1.0154 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 46.22 | 27.76 | 3114 | 4125 | 0.7549 | 0.9236 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 46.22 | 27.76 | 3326 | 4125 | 0.8063 | 0.9412 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 47.93 | 27.76 | 229 | 4421 | 0.0518 | 0.3344 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 47.93 | 27.76 | 4707 | 4421 | 1.0646 | 1.0172 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 47.93 | 27.76 | 3145 | 4421 | 0.7113 | 0.9090 | MN20160318_Q01 | M03 |